Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX)

CUSIP: 74365A309

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
80,165,500
Total 13F shares
4,761,719
Share change
-498,742
Total reported value
$18,443,257
Put/Call ratio
35%
Price per share
$3.87
Number of holders
23
Value change
-$1,925,407
Number of buys
10
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 74365A309?
CUSIP 74365A309 identifies PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) as of Q3 2020

As of 30 Sep 2020, Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,761,719 shares. The largest 10 holders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, Psagot Investment House Ltd., UBS OCONNOR LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, Phoenix Holdings Ltd., BANK OF MONTREAL /CAN/, KENNEDY CAPITAL MANAGEMENT, INC., ETF MANAGERS GROUP, LLC, and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM. This page lists 23 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.